From January 18, 2024 to March 31, 2024, the company has repurchased 2,476,300 shares, representing 0.27% for HKD 60.36 million. With this, the company has completed the repurchase of 2,476,300 shares, representing 0.27% for HKD 60.36 million under the buyback announced on January 19, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.62 CNY | -0.54% | +0.17% | +16.02% |
14/05 | Livzon Pharmaceutical Group Cancels Share Options | MT |
14/05 | Livzon Pharmaceutical Declares Final Dividend for 2023 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.02% | 462.48Cr | |
+30.86% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 29TCr | |
+14.87% | 24TCr | |
+9.82% | 21TCr | |
-7.81% | 20TCr | |
+8.12% | 17TCr | |
-1.42% | 16TCr |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Tranche Update on Livzon Pharmaceutical Group Inc.'s Equity Buyback Plan announced on January 19, 2024.